A framework for physician assistant intervention for overweight and obesity

AbstractOverweight and obesity compose a chronic disease process of epidemic proportions that presents on a continuum, likely affecting nearly two out of every three patients treated by physician assistants (PAs). However, meaningful and actionable definitions, including but not limited to anthropometric and clinical descriptors, are needed. The effective treatment of overweight and obesity requires an efficient and timely process of screening, diagnosis, evaluation of complications, staging, and clear algorithmic management. PAs are trained as primary care providers and can diagnose and treat overweight and obese patients regardless of practice setting and across the spectrum of the disease and patient's age.

[1]  G. Bray,et al.  American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[2]  Robert F Kushner,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[3]  J. Danesh,et al.  Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.

[4]  D. Cook,et al.  Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies , 2009, International Journal of Obesity.

[5]  F. Hu,et al.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. , 2007, Archives of internal medicine.

[6]  Hendriek C Boshuizen,et al.  Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. , 2006, American journal of epidemiology.

[7]  Cliona Ni Mhurchu,et al.  Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studies. , 2002, Seminars in vascular medicine.